Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00489307 · ClinicalTrials.gov registry record · Phase 2

Dexamethasone for Symptom Burden in Advanced Cancer Patients

A Phase 2 study of Solid Tumors, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
Phase 2
Development phase
132
Enrollment target
2
Study locations

NCT00489307 is a Phase 2 study of Solid Tumors that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 132 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00489307, a Phase 2 study of Solid Tumors, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
132 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical research study is to learn if dexamethasone can help to control symptoms such as fatigue, pain, nausea, weight loss, loss of appetite, sleep problems, and/or depression in patients with advanced cancer.

Conditions Studied

Solid Tumors

Interventions

  • DRUG Placebo
  • DRUG Dexamethasone

Study Locations (2)

Texas

  • Lyndon Baines Johnson Hospital - Houston
  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2006-02-02
Est. Completion 2028-02-28
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00489307

The ClinicalTrials.gov registry entry for NCT00489307 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (54% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00489307 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00489307 about?

NCT00489307 is a clinical study titled "Dexamethasone for Symptom Burden in Advanced Cancer Patients". The goal of this clinical research study is to learn if dexamethasone can help to control symptoms such as fatigue, pain, nausea, weight loss, loss of appetite, sleep problems, and/or depression in patients with advanced cancer.

What is the current status of trial NCT00489307?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2006-02-02. Estimated completion is 2028-02-28.

What conditions does trial NCT00489307 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT00489307?

The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT00489307?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00489307 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.